Suppr超能文献

戈谢病与帕金森病的分子关联理论。

Gaucher disease and parkinsonism, a molecular link theory.

机构信息

Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892-3708, USA.

出版信息

Mol Genet Metab. 2010 Dec;101(4):307-10. doi: 10.1016/j.ymgme.2010.08.004. Epub 2010 Aug 10.

Abstract

Mutant GBA was found recently to be the most prevalent risk factor for familial parkinsonism. The two diseases do not share common symptoms and there is no direct pathway to explain the mechanism by which GBA mutations can confer the risk. Increased burden on the degradative pathway caused by defective glucocerebrosidase, or toxic side effects of glycosylated lipids accumulation were proposed to explain brain damage. Both hypotheses are not sufficient to explain the linkage. In order to develop a more inclusive theory we introduced into the model the prion theory and the second hit. Other possibilities are also brought into consideration.

摘要

最近发现,突变 GBA 是家族性帕金森病最常见的风险因素。这两种疾病没有共同的症状,也没有直接的途径可以解释 GBA 突变如何带来风险。有人提出,葡萄糖脑苷脂酶缺陷导致降解途径负担增加,或糖基化脂质积累的毒性副作用,可能导致大脑损伤。这两种假说都不足以解释这种关联。为了提出一个更具包容性的理论,我们将朊病毒理论和二次打击引入到模型中。同时也考虑了其他可能性。

相似文献

1
Gaucher disease and parkinsonism, a molecular link theory.
Mol Genet Metab. 2010 Dec;101(4):307-10. doi: 10.1016/j.ymgme.2010.08.004. Epub 2010 Aug 10.
2
Parkinsonism among Gaucher disease carriers.
J Med Genet. 2004 Dec;41(12):937-40. doi: 10.1136/jmg.2004.024455.
3
Exploring the link between glucocerebrosidase mutations and parkinsonism.
Trends Mol Med. 2011 Sep;17(9):485-93. doi: 10.1016/j.molmed.2011.05.003. Epub 2011 Jul 1.
4
The association between ß-glucocerebrosidase mutations and parkinsonism.
Curr Neurol Neurosci Rep. 2013 Aug;13(8):368. doi: 10.1007/s11910-013-0368-x.
5
Glucocerebrosidase mutations in subjects with parkinsonism.
Mol Genet Metab. 2004 Jan;81(1):70-3. doi: 10.1016/j.ymgme.2003.11.004.
6
The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease.
Neuron. 2017 Feb 22;93(4):737-746. doi: 10.1016/j.neuron.2017.01.018.
7
The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations.
Arch Neurol. 2008 Oct;65(10):1353-7. doi: 10.1001/archneur.65.10.1353.
9
Gaucher-Associated Parkinsonism.
Cell Mol Neurobiol. 2015 Aug;35(6):755-61. doi: 10.1007/s10571-015-0176-8. Epub 2015 Mar 29.
10
Parkinsonism, dementia and glucocerebrosidase mutations.
J Neurol. 2013 May;260(5):1441-4. doi: 10.1007/s00415-013-6923-1.

引用本文的文献

1
Ideal animal models according to multifaceted mechanisms and peculiarities in neurological disorders: present and challenges.
Arch Pharm Res. 2025 Jan;48(1):62-88. doi: 10.1007/s12272-024-01527-9. Epub 2024 Dec 18.
2
A review on Gaucher disease: therapeutic potential of β-glucocerebrosidase-targeted mRNA/saRNA approach.
Int J Biol Sci. 2024 Mar 17;20(6):2111-2129. doi: 10.7150/ijbs.87741. eCollection 2024.
3
Animal models of Parkinson's disease: bridging the gap between disease hallmarks and research questions.
Transl Neurodegener. 2023 Jul 19;12(1):36. doi: 10.1186/s40035-023-00368-8.
4
Fabry Disease With Concomitant Lewy Body Disease.
J Neuropathol Exp Neurol. 2020 Apr 1;79(4):378-392. doi: 10.1093/jnen/nlz139.
6
Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice.
Hum Mol Genet. 2014 Aug 1;23(15):3943-57. doi: 10.1093/hmg/ddu105. Epub 2014 Mar 5.
7
Loss of β-glucocerebrosidase activity does not affect alpha-synuclein levels or lysosomal function in neuronal cells.
PLoS One. 2013 Apr 8;8(4):e60674. doi: 10.1371/journal.pone.0060674. Print 2013.
9
The link between the GBA gene and parkinsonism.
Lancet Neurol. 2012 Nov;11(11):986-98. doi: 10.1016/S1474-4422(12)70190-4.
10
Gaucher disease and the synucleinopathies: refining the relationship.
Orphanet J Rare Dis. 2012 Jan 31;7:12. doi: 10.1186/1750-1172-7-12.

本文引用的文献

1
The role of the lipid bilayer in tau aggregation.
Biophys J. 2010 Jun 2;98(11):2722-30. doi: 10.1016/j.bpj.2010.03.013.
2
The propagation of prion-like protein inclusions in neurodegenerative diseases.
Trends Neurosci. 2010 Jul;33(7):317-25. doi: 10.1016/j.tins.2010.04.003. Epub 2010 May 20.
3
Prion-like disorders: blurring the divide between transmissibility and infectivity.
J Cell Sci. 2010 Apr 15;123(Pt 8):1191-201. doi: 10.1242/jcs.051672.
5
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.
N Engl J Med. 2009 Oct 22;361(17):1651-61. doi: 10.1056/NEJMoa0901281.
6
Immune cell types involved in early uptake and transport of recombinant mouse prion protein in Peyer's patches of calves.
Cell Tissue Res. 2009 Dec;338(3):343-54. doi: 10.1007/s00441-009-0879-6. Epub 2009 Oct 16.
8
Is Parkinson's disease a prion disorder?
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12571-2. doi: 10.1073/pnas.0906759106. Epub 2009 Jul 28.
9
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein.
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):13010-5. doi: 10.1073/pnas.0903691106. Epub 2009 Jul 27.
10
Recommendations on the diagnosis and management of Niemann-Pick disease type C.
Mol Genet Metab. 2009 Sep-Oct;98(1-2):152-65. doi: 10.1016/j.ymgme.2009.06.008. Epub 2009 Jun 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验